+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Intracranial Stents Total Addressable Market Size, Share & Trends Analysis Report by Application (Intracranial Stenosis, Brain Aneurysm), by Product, by End User, by Region, and Segment Forecasts, 2022-2030

  • ID: 5595826
  • Report
  • April 2022
  • Region: Global
  • 136 Pages
  • Grand View Research

FEATURED COMPANIES

  • Abbott
  • Acandis GmbH
  • Balt
  • Medtronic
  • Microvention Inc.
  • Stryker
The global intracranial stents total addressable market size is anticipated to reach USD 4.1 billion by 2030. The market is expected to expand at a notable CAGR of 4.8% from 2022 to 2030. Increasing product developments, rising prevalence of intracranial disorders, growing awareness among the general public, and supportive initiatives undertaken by public and private healthcare organizations are some of the key factors fueling the market. The Brain Foundation in Australia, for instance, supports the funding of quality research in neurological diseases, disorders, and injuries, to help advance diagnoses and treatments, improving patient outcomes.



The COVID-19 pandemic has adversely affected the number of elective surgeries during 2020 and 2021. The pandemic has affected market players and consumers in different ways, such as moving businesses online and restricted access to healthcare providers. Supply chain disruptions and operational hurdles were observed due to changing policies and restrictions during the pandemic. The disease outbreak has had a major impact on the treatment of stroke. Numerous reports have emphasized on a decline in the rate of hospital admissions for medical emergencies such as stroke or myocardial infarction. For instance, 12,546 patients were hospitalized between January and September 2020 for carotid artery surgery in France. This figure was 9.8% lower than the same period in the three preceding years (2017-2019)

Rapid adoption of novel technologies and emerging treatment options, increasing clinical trials, and strategic initiatives undertaken by key market players are factors expected to propel the market in the coming years. Acandis, headquartered in Germany, offers the Credo stent for treatment of intracranial stenosis. Credo is a self-expanding nitinol stent suitable for vessels within a diameter range of 2.0-4.5 mm. In August 2018, Cerenovus, part of Johnson & Johnson received CE mark for its BRAVO Flow Diverter intended for the treatment of intracranial aneurysms, in Europe. This enabled the company to commercialize the product.

Asia Pacific held the leading share of the market in 2021 owing to the presence of a large patient population, key companies, the prevalence of risk factors such as atherosclerosis, and improving healthcare infrastructure. The Asian-Pacific Society of Atherosclerosis and Vascular Diseases provides a forum highlighting similarities and differences of the disease across the region. It also supports regional collaboration on common research interests. According to the UN Department of Economics and Social Affairs, population in Asia was estimated at 4.64 billion in 2020, which increased to 4.67 billion in 2021.

Intracranial Stents Total Addressable Market Report Highlights

  • The market was valued at USD 2.7 billion in 2021 and is expected to witness a CAGR of 4.8% during the forecast period.
  • Increasing incidence of intracranial disorders, technological advancements, and strategic initiatives by key companies are expected to drive the market growth in the near future.
  • On the basis of product, self-expanding stents accounted for the largest revenue share in 2021.
  • The balloon-expanding and other stents segment dominated the market in 2021. This is owing to growing R&D and adoption of flow diverter devices and drug-eluting stents.
  • Intracranial stenosis, on the other hand, held the dominant share in terms of applications.
  • The brain aneurysm segment is expected to grow the fastest over the forecast period. The rising number of people suffering from intracranial disorders and growing preference for minimally invasive surgeries are anticipated to fuel market growth.
  • The hospitals segment held the largest revenue share in 2021.
  • Asia Pacific contributed to the highest market share by region in 2021 while North America is projected to grow the fastest over the forecast period.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Intracranial Stents Total Addressable Market

What is the estimated value of the Global Intracranial Stents Total Addressable Market?

The Global Intracranial Stents Total Addressable Market was estimated to be valued at $2.8 Billion in 2022.

What is the growth rate of the Global Intracranial Stents Total Addressable Market?

The growth rate of the Global Intracranial Stents Total Addressable Market is 4.8%, with an estimated value of $4.1 Billion by 2030.

What is the forecasted size of the Global Intracranial Stents Total Addressable Market?

The Global Intracranial Stents Total Addressable Market is estimated to be worth $4.1 Billion by 2030.

Who are the key companies in the Global Intracranial Stents Total Addressable Market?

Key companies in the Global Intracranial Stents Total Addressable Market include Optimed Medizinische Instrumente GmbH, Medtronic, Acandis GmbH, Microport Scientific Corporation, Microvention Inc., Cerenovus (Johnson & Johnson), Sino Medical Sciences Technology Inc., Stryker and Balt.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Acandis GmbH
  • Balt
  • Medtronic
  • Microvention Inc.
  • Stryker

Chapter 1. Research Methodology & Scope
1.1 Market Segmentation & Scope
1.2 Estimates and Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.5 Purchased Database:
1.6 Internal Database
1.7 Secondary Sources
1.8 Primary Research:
1.9 Details Of Primary Research
1.10 Information Or Data Analysis
1.11 Data Analysis Models
1.12 Market Formulation & Validation
1.13 Model Details
1.13.1 Total Addressable Market
1.13.1.1 Estimating The Number Of Cases Requiring Intracranial Stenting
1.13.1.2 Estimating The Intracranial Stents Tam
1.13.2 Estimating Asp by Product Segments At Global and Regional Levels (2021)
1.13.3 Estimating Total Number Of Units Sold At Global and Regional Levels
1.14 List Of Secondary Sources
Chapter 2. Executive Summary
2.1 Intracranial Stents Total Addressable Market Summary, 2021
Chapter 3. Intracranial Stents: Industry Outlook
3.1 Parent Market Outlook
3.2 Ancillary Market Outlook
3.3 Penetration & Growth Prospect Mapping
3.4 Market Dynamics
3.5 Market Driver Analysis
3.6 Market Restraint Analysis
3.7 Porter’s Five Forces Analysis
3.7.1 Bargaining Power Of Suppliers:
3.7.2 Bargaining Power Of Buyers:
3.7.3 Threat Of Substitutes:
3.7.4 Threat Of New Entrants:
3.7.5 Competitive Rivalry:
3.8 Pestle Analysis (Political & Legal, Economic, Social, Technological, and Environmental Landscape)
3.8.1 Political/Legal Landscape
3.8.2 Economic Landscape
3.8.3 Social Landscape
3.8.4 Technology Landscape
3.8.5 Environment Landscape
3.9 Regulatory Framework
3.10 Technology Overview
3.11 Product Pipeline Analysis
3.12 Estimated Number Of Cases Requiring Intracranial Stenting At Global and Regional Levels
3.13 Estimated Cost Of Procedure by Application
3.14 Total Estimated Number Of Units Sold At Global and Regional Levels
3.15 Estimated Asps by Product Segments At Global and Regional Levels (2021)
Chapter 4. Covid-19 Impact Analysis
4.1 Impact Of Covid-19
4.1.1 Current and Future Impact Analysis
4.1.2 Future Impact Analysis
4.1.3 Impact On Market Players
Chapter 5. Intracranial Stents Total Addressable Market: Product Estimates & Trend Analysis
5.1 Product Market Share Analysis, 2021 & 2030
5.2 Product Dashboard
5.3 Embolization Coil Support Intracranial Stents
5.3.1 Embolization Coil Support Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
5.4 Self-Expanding Stents
5.4.1 Self-Expanding Stents Market Estimates and Forecasts, 2017-2030 (USD Million)
5.5 Other Products
5.5.1 Others Market Estimates and Forecasts, 2017-2030 (USD Million)
5.5.2 Venous Sinus Stents
5.5.2.1 Adoption Trends Of Venous Sinus Stenting
5.5.2.2 Venous Sinus Stents Market Estimates and Forecasts, 2017-2030 (USD Million)
5.5.3 Balloon-Expanding & Other Stents
5.5.3.1 Balloon-Expanding & Other Stents Market Estimates and Forecasts, 2017-2030 (USD Million)
Chapter 6. Intracranial Stents Total Addressable Market: Application Estimates & Trend Analysis
6.1 Application Market Share Analysis, 2021 & 2030
6.2 Application Dashboard
6.3 Intracranial Stenosis
6.3.1 Intracranial Stenosis Market Estimates and Forecasts, 2017-2030 (USD Million)
6.4 Brain Aneurysm
6.4.1 Brain Aneurysm Market Estimates and Forecasts, 2017-2030 (USD Million)
6.5 Others (Iih Etc.)
6.5.1 Others Market Estimates and Forecasts, 2017-2030 (USD Million)
Chapter 7. Intracranial Stents Total Addressable Market: End-User Estimates & Trend Analysis
7.1 End-User Market Share Analysis, 2021 & 2030
7.2 End-User Dashboard
7.3 Hospitals
7.3.1 Hospitals Market Estimates and Forecasts, 2017-2030 (USD Million)
7.4 Ambulatory Surgical Centers
7.4.1 Ambulatory Surgical Centers Market Estimates and Forecasts, 2017-2030 (USD Million)
7.5 Other End-Users
7.5.1 Other End-Users Market Estimates and Forecasts, 2017-2030 (USD Million)
Chapter 8. Intracranial Stents Total Addressable Market: Regional Estimates & Trend Analysis
8.1 Regional Market Snapshot
8.2 Region Market Share Analysis, 2021 & 2030
8.3 North America
8.3.1 North America Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.3.2 U.S.
8.3.2.1 U.S. Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.3.3 Canada
8.3.3.1 Canada Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.4 Europe
8.4.1 Europe Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.4.2 U.K.
8.4.2.1 U.K. Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030(USD Million)
8.4.3 Germany
8.4.3.1 Germany Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.4.4 France
8.4.4.1 France Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.4.5 Italy
8.4.5.1 Italy Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.4.6 Spain
8.4.6.1 Spain Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.5 Asia Pacific
8.5.1 Asia Pacific Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.5.2 Japan
8.5.2.1 Japan Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.5.3 China
8.5.3.1 China Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.5.4 India
8.5.4.1 India Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.5.5 Australia
8.5.5.1 Australia Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.5.6 South Korea
8.5.6.1 South Korea Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.6 Latin America
8.6.1 Latin America Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.6.2 Mexico
8.6.2.1 Mexico Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.6.3 Brazil
8.6.3.1 Brazil Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.6.4 Argentina
8.6.4.1 Argentina Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.7 Middle East & Africa (MEA)
8.7.1 Mea Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.7.2 South Africa
8.7.2.1 South Africa Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
8.7.3 Saudi Arabia
8.7.3.1 Saudi Arabia Intracranial Stents Total Addressable Market Estimates and Forecasts, 2017-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1 Company Profiles
9.1.1 Optimed Medizinische Instrumente Gmbh
9.1.1.1 Company Overview
9.1.1.2 Financial Performance
9.1.1.3 Product Benchmarking
9.1.2 Medtronic
9.1.2.1 Company Overview
9.1.2.2 Financial Performance
9.1.2.3 Product Benchmarking
9.1.2.4 Strategic Initiatives
9.1.3 Acandis Gmbh
9.1.3.1 Company Overview
9.1.3.2 Financial Performance
9.1.3.3 Product Benchmarking
9.1.4 Microport Scientific Corporation
9.1.4.1 Company Overview
9.1.4.2 Financial Performance
9.1.4.3 Product Benchmarking
9.1.4.4 Strategic Initiatives
9.1.5 Microvention Inc.
9.1.5.1 Company Overview
9.1.5.2 Financial Performance
9.1.5.3 Product Benchmarking
9.1.5.4 Strategic Initiatives
9.1.6 Cerenovus (Johnson & Johnson)
9.1.6.1 Company Overview
9.1.6.2 Financial Performance
9.1.6.3 Product Benchmarking
9.1.6.4 Strategic Initiatives
9.1.7 Sino Medical Sciences Technology Inc.
9.1.7.1 Company Overview
9.1.7.2 Financial Performance
9.1.7.3 Product Benchmarking
9.1.7.4 Strategic Initiatives
9.1.8 Stryker
9.1.8.1 Company Overview
9.1.8.2 Financial Performance
9.1.8.3 Product Benchmarking
9.1.8.4 Strategic Initiatives
9.1.9 Abbott
9.1.9.1 Company Overview
9.1.9.2 Financial Performance
9.1.9.3 Product Benchmarking
9.1.9.4 Strategic Initiatives
9.1.10 Balt
9.1.10.1 Company Overview
9.1.10.2 Financial Performance
9.1.10.3 Product Benchmarking
9.2 Market Participation Categorization
9.3 Company Market Share Analysis, 2021
9.4 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Key Alliances)
9.5 Synergy Analysis: Major Deals & Strategic Alliances
9.6 List Of Companies
Note: Product cover images may vary from those shown
  • Optimed Medizinische Instrumente GmbH
  • Medtronic
  • Acandis GmbH
  • Microport Scientific Corporation
  • Microvention Inc.
  • Cerenovus (Johnson & Johnson)
  • Sino Medical Sciences Technology Inc.
  • Stryker
  • Abbott
  • Balt
Note: Product cover images may vary from those shown

Loading
LOADING...